US 11365189
Heterocyclic inhibitors of tyrosine kinase
granted A61PA61P35/04
Quick answer
US patent 11365189 (Heterocyclic inhibitors of tyrosine kinase) held by The Board of Regents of the University of Texas System expires Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jun 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61P, A61P35/04